Today we announced that the company will host a webcast conference call to report its second quarter 2024 financial results and provide an update on the company's business and outlook on Thursday, August 8 at 4:30 p.m. ET. Read more: https://bit.ly/4cTQiZq
PTC Therapeutics, Inc.
Biotechnology Research
We're committed to a single purpose: Extending life’s moments for patients with rare diseases and their loved ones.
About us
PTC is a patient-centered biopharmaceutical company focused on discovering, developing & commercializing medicine for patients with rare and serious disease.
- Website
-
https://ptcbio.com/
External link for PTC Therapeutics, Inc.
- Industry
- Biotechnology Research
- Company size
- 501-1,000 employees
- Type
- Public Company
- Founded
- 1998
- Specialties
- Orphan and Ultra-orphan Disorders, Oncology, and Anti-infectives
Locations
-
Primary
-
500 Warren Corporate Center Drive
Warren, NJ 07059, US
Employees at PTC Therapeutics, Inc.
Updates
-
📣 Leadership Announcement 📣 🌟 We're thrilled to announce that Kylie O'Keefe has been promoted to the role of Chief Strategy Officer, where she'll provide strategic oversight of PTC products from pipeline to launch. Kylie has extensive experience leading cross-functional teams, assets, and brands across the full drug development pathway. With an entrepreneurial and innovative mindset, and the ability to transform vision into results, we are excited to see the impact she'll have on PTC's future. Join us in congratulating Kylie and learn more about our leadership team that's shaping the future of rare diseases: https://bit.ly/4ccqRRL
-
-
Phenylketonuria, or #PKU, affects the body's ability to metabolize proteins. It requires a strict monitoring of diet, but has many other challenges and nuances for those diagnosed with PKU and their loved ones. We honor the strength and resilience of the PKU community in our My VIBE podcast, where Sam, Maridith and Lauren share their experiences living with PKU. Listen to full episodes to learn more:https://bit.ly/3QA1SzH
-
Our core mission is helping people and those impacted by rare diseases. This week, we’re proud to be a sponsor of the National PKU Alliance’s 2024 Conference in Virginia. We look forward to attending and meeting with conference attendees to share our insights and learn from the community. Come meet our team members onsite at our booth! #NPKUA #NPKUA2024CONFERENCE Malisa R. Aurora E. Flores, MPH Frank Quintieri Karina Lambertini Emily Hintze
-
📣 Leadership Announcement 📣 🚀 We are excited to have Adrian Haigh return to PTC to lead the company's growth in emerging markets within the CIS/MENA/APAC/Japan regions. In this new role, Adrian will play an important part in strengthening our geographic footprint throughout these key rare disease markets. With his extensive senior management experience in building and leading international commercial operations, we're thrilled to have Adrian support, mentor, and develop the next generation of senior commercial leaders across this exciting region for PTC. Join us in congratulating Adrian!
-
-
PTC UK was the first office to open in Europe 10 years ago and realize PTC’s mission of improving the lives of people living with rare disease in the region. On this milestone anniversary, our most tenured employees reflect on the company's journey in the UK throughout the past decade. Read more: https://bit.ly/3LgLJfz #PTCEurope10
-
At PTC, we invest in our people and dedicate resources to development and learning, ensuring our employees are supported and empowered in their careers. Learn more: https://bit.ly/3LfrQVU
-
-
Our PTC team was proud to attend and participate in Parent Project Muscular Dystrophy’s 30th Annual Conference last weekend in Orlando, FL and meet those living with #Duchenne muscular dystrophy, their caregivers, leading experts and researchers, and industry partners. We continue to learn from and feel inspired by this incredible community. #PPMDeveryfuture
-
We are honored to receive this year's ‘Best Strategic Partnership’ award at the Life Science Industry Awards in Ireland. Thank you to our valued business partners Almac Group and World Courier for their vital role in helping us deliver innovative therapies to patients worldwide. Congratulations to all finalists and winners! #LifeScienceAwards2024 #LifeSciences #Innovation
-
-
Phenylketonuria, or PKU, is a rare, inherited metabolic disease, which affects the brain. If left untreated or poorly managed, it can cause severe and irreversible disabilities. On June 28, along with the #PKU community, we're honoring International PKU Awareness Day by sharing the facts behind some common myths about PKU. #InternationalPKUDay #PKUDay2024
Affiliated pages
Similar pages
Browse jobs
Stock
PTCT
NASDAQ
20 minutes delay
$32.52
-1.57 (-4.606%)
- Open
- 34.08
- Low
- 32.18
- High
- 34.08
Data from Refinitiv
See more info on